Effects of Consumption of Phosphatidylserine on the Cognitive Function

Exclusion Criteria

• •1. Subjects undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction
• •2. Subjects carrying a pacemaker or an implantable cardioverter defibrillator (ICD)
• •3. Subjects undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
• •4. Subjects who have dementia
• •5. Subjects who have mental health issues such as depression disorder, attention deficit/hyperactivity disorder (ADHD), or other issues
• •6. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage, as part of their daily intake
• •7. Subjects who take supplements or foods that may improve cognitive functions, such as phosphatidylserine, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), ginkgo leaf extract, tocotrienol, astaxanthin, gamma-aminobutyric acid (GABA), and plasmalogen, as part of their daily intake
• •8. Subjects who take blue-backed fish such as sardines, mackerel, and saury for 4 days/week or over
• •9. Subjects who use devices, equipment, and applications that may affect cognitive functions (e.g., brain training puzzles, brain training games) as part of their daily life
• •10. Subjects regularly taking medications (including herbal medicines) and supplements
• •11. Subjects who are allergic to medications and/or the test food related products
• •12. Subjects who are pregnant, breast-feeding or planning for pregnancy during the trial period
• •13. Subjects who have been enrolled in other clinical trials 28 days before the agreement to participate in this trial or those who plan to enroll in another clinical trial during the trial period
• •14. Subjects who are deemed ineligible to participate by the principal investigator